ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,552.00
      0.74%
      Dow Jones
      38,834.86
      0.00%
      Brent Oil
      84.705
      0.01%
      Bitcoin
      66,067.92
      1.69%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BridgeBio Pharma Inc (BBIO)

      7. BridgeBio Pharma Inc (BBIO) News

      BBIO BridgeBio Pharma Inc

      27.61
      0.00 (0.00%)
      Pre Market
      Last Updated: 07:35:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      BridgeBio Pharma Inc BBIO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 27.61 07:35:00
      Open Price Low Price High Price Close Price Prev Close
      27.61
      more quote information »

      Recent News

      Date Time Source Heading
      6/18/202407:30GLOBEBridgeBio Pharma Surpasses Interim Analysis Enrollment..
      6/10/202407:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
      6/06/202407:30GLOBEBridgeBio Pharma to Participate in the 45th Annual Goldman..
      6/06/202406:01EDGAR2Form 8-K - Current report
      6/04/202407:30GLOBEBridgeBio Announces Durable Month 12 and 18 Phase 2 Cohort 5..
      6/03/202416:01GLOBEBridgeBio to Host Call on Month 12 and 18 Phase 2 Cohort 5..
      5/29/202416:01GLOBEAdditional Data Showing Acoramidis Increases Serum..
      5/24/202407:30GLOBEBridgeBio Pharma to Present Additional Analyses from the..
      5/17/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      5/15/202407:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
      5/14/202407:30GLOBEBridgeBio Pharma to Participate in the Bank of America..
      5/13/202407:30GLOBEBridgeBio Pharma Presents Additional Data and Analyses from..
      5/02/202407:30GLOBEBridgeBio Pharma Reports First Quarter 2024 Financial..
      5/02/202407:00GLOBEBridgeBio launches BridgeBio Oncology Therapeutics (BBOT)..
      4/10/202407:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
      4/07/202413:15GLOBEBridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR)..
      3/20/202407:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
      3/06/202417:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/06/202417:13EDGAR2Form 8-K - Current report
      3/05/202423:53GLOBEBridgeBio Pharma Announces Pricing of Public Offering of..
      3/04/202417:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      3/04/202416:17GLOBEBridgeBio Pharma Announces Proposed Public Offering of..
      3/04/202407:00EDGAR2Form 8-K - Current report
      3/04/202402:30GLOBEBridgeBio Pharma and Bayer Announce European Licensing..
      2/22/202416:27EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/22/202407:31EDGAR2Form 8-K - Current report
      2/22/202407:30GLOBEBridgeBio Pharma Reports Fourth Quarter and Full Year 2023..
      2/21/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/20/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/15/202416:06EDGAR2Form 144 - Report of proposed sale of securities
      2/13/202416:05EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
      2/13/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/07/202407:34GLOBEBridgeBio Pharma and Kyowa Kirin Announce Partnership with..
      2/06/202407:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
      2/05/202407:30GLOBEBridgeBio Pharma Announces U.S. Food and Drug Administration..
      2/02/202407:00GLOBEBridgeBio Pharma Shares Positive Results of Single-Arm Phase..
      1/30/202407:00PRNUSInvitae Partners with BridgeBio Pharma to Harness Genetic..
      1/18/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/18/202407:30EDGAR2Form 8-K - Current report
      1/18/202407:00GLOBEBridgeBio Pharma Secures up to $1.25 Billion of Capital from..
      1/16/202416:04EDGAR2Form 144 - Report of proposed sale of securities
      1/10/202417:15GLOBEBridgeBio Pharma Announces Publication of Positive Results..
      1/10/202407:30GLOBEBridgeBio Pharma Reports Inducement Grants under Nasdaq..
      1/08/202417:14EDGAR2Form 8-K - Current report
      1/05/202416:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
      1/03/202416:30GLOBEBridgeBio Pharma to Participate in the J.P. Morgan..
      1/03/202407:30GLOBEBridgeBio announces FDA clearance of IND application for..
      12/19/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/15/202316:13EDGAR2Form 144 - Report of proposed sale of securities
      12/13/202307:30GLOBEBridgeBio Announces First Child Dosed in PROPEL 3, its Phase..

      Your Recent History

      NASDAQ
      BBIO
      BridgeBio Pharma
      Delayed Upgrade Clock